Tri Chemical Laboratories Inc. (JP:4369)
:4369
Want to see JP:4369 full AI Analyst Report?
Top Page
Tri Chemical Laboratories Inc.
(4369)
Select Model
Select Model
Rating:76Outperform
Price Target:
¥3,678.00
▲(35.72% Upside)
Action:Upgraded
Date:05/14/26
The score is driven primarily by solid overall fundamentals (strong growth, profitability, and low leverage) tempered by weak 2026 cash-flow quality, while technicals are notably supportive with a strong uptrend and positive momentum. Valuation is reasonable but not especially cheap, and dividends are modest.
Positive Factors
Revenue Growth
Sustained double-digit top-line growth reflects expanding market share in high-purity chemicals for semiconductors and electronics. Coupled with the company’s product focus, this durable demand profile supports long-term revenue visibility and scale benefits across the business.
Negative Factors
Weak Cash Conversion
A material swing to negative free cash flow and OCF covering ~50% of net income reduces financial flexibility and raises questions on earnings quality. Over months, constrained cash generation can force external financing, delay investments, or pressure margins under stress.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Sustained double-digit top-line growth reflects expanding market share in high-purity chemicals for semiconductors and electronics. Coupled with the company’s product focus, this durable demand profile supports long-term revenue visibility and scale benefits across the business.
Read all positive factors
Tri Chemical Laboratories Inc. (4369) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥113.74B
Dividend Yield1.3%
Average Volume (3M)842.32K
Price to Earnings (P/E)17.9
Beta (1Y)1.24
Revenue Growth26.33%
EPS Growth11.15%
CountryJP
Employees274
SectorBasic Materials
Sector Strength58
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)169.71
Shares Outstanding32,498,640
10 Day Avg. Volume589,290
30 Day Avg. Volume842,316
Financial Highlights & Ratios
PEG Ratio1.74
Price to Book (P/B)2.97
Price to Sales (P/S)4.49
P/FCF Ratio-43.05
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)161.05
Revenue Forecast (FY)¥27.70B
Tri Chemical Laboratories Inc. Business Overview & Revenue Model
Company Description
Tri Chemical Laboratories Inc. provides precursors for semiconductors, optical fibers, solar cells, and compound semiconductors. It also offers catalysts, special reagents, etc. In addition, the company provides containers, such as stainless-steel...
How the Company Makes Money
The company generates revenue by designing, manufacturing, and selling high-purity chemical products to semiconductor manufacturers and other players in the electronics industry. It serves as a vital supplier of advanced materials used in wafer pr...
Tri Chemical Laboratories Inc. Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
86
Very Positive
Cash Flow
55
Neutral
| Breakdown | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 23.88B | 18.91B | 11.25B | 13.80B | 11.57B |
| Gross Profit | 9.02B | 7.95B | 4.02B | 5.51B | 4.77B |
| EBITDA | 7.82B | 6.63B | 3.25B | 4.71B | 4.00B |
| Net Income | 5.52B | 4.96B | 2.47B | 4.83B | 4.10B |
Balance Sheet | |||||
| Total Assets | 47.27B | 37.13B | 31.86B | 32.12B | 28.44B |
| Cash, Cash Equivalents and Short-Term Investments | 7.28B | 9.44B | 10.50B | 11.14B | 8.03B |
| Total Debt | 4.13B | 1.78B | 2.40B | 3.24B | 4.28B |
| Total Liabilities | 11.13B | 5.54B | 4.29B | 6.24B | 7.12B |
| Stockholders Equity | 36.15B | 31.59B | 27.57B | 25.88B | 21.32B |
Cash Flow | |||||
| Free Cash Flow | -2.49B | 605.75M | 1.23B | 4.86B | 2.76B |
| Operating Cash Flow | 3.80B | 3.68B | 2.97B | 6.39B | 3.64B |
| Investing Cash Flow | -7.05B | -3.12B | -1.78B | -1.56B | -932.88M |
| Financing Cash Flow | 1.09B | -1.62B | -1.86B | -1.70B | 3.59B |
Tri Chemical Laboratories Inc. Technical Analysis
Positive
2710.00
Price Trends
3059.44
Positive
3139.41
Positive
3027.08
Positive
Market Momentum
92.98
Positive
59.20
Neutral
33.97
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4369, the sentiment is Positive. The current price of 2710 is below the 20-day moving average (MA) of 3340.75, below the 50-day MA of 3059.44, and below the 200-day MA of 3027.08, indicating a bullish trend. The MACD of 92.98 indicates Positive momentum. The RSI at 59.20 is Neutral, neither overbought nor oversold. The STOCH value of 33.97 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4369.
Tri Chemical Laboratories Inc. Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥112.73B | 7.03 | 9.19% | 3.33% | -10.12% | 276.36% | |
76 Outperform | ¥113.74B | 17.95 | ― | 1.30% | 26.33% | 11.15% | |
74 Outperform | ¥115.86B | 18.70 | 15.07% | 1.74% | 7.82% | 64.90% | |
74 Outperform | ¥91.16B | 11.05 | ― | 3.02% | 0.51% | 3.23% | |
73 Outperform | ¥76.51B | 9.11 | ― | 3.04% | -0.37% | -20.95% | |
70 Outperform | ¥88.97B | 7.14 | ― | 3.74% | 0.53% | 30.98% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
* Basic Materials Sector Average
JP:4369
Tri Chemical Laboratories Inc.
3,500.00
637.09
22.25%
JP:4471
Sanyo Chemical Industries
5,110.00
1,567.94
44.27%
JP:4187
Osaka Organic Chemical Industry Ltd.
5,230.00
2,843.92
119.19%
JP:4008
Sumitomo Seika Chemicals Co., Ltd.
1,275.00
422.10
49.49%
JP:4116
Dainichiseika Color & Chemicals Mfg.Co., Ltd.
1,058.00
315.37
42.47%
JP:4956
Konishi Co., Ltd.
1,395.00
296.51
26.99%
Tri Chemical Laboratories Inc. Corporate Events
Tri Chemical Laboratories Posts Double-Digit Sales and Profit Growth for FY2025
Mar 13, 2026
Tri Chemical Laboratories reported strong consolidated results for the fiscal year ended January 31, 2026, with net sales rising 26.3% to ¥23.88 billion and operating profit up 12.3% to ¥5.90 billion. Ordinary profit increased 7.7% to &#...
Tri Chemical Labs Moves to One-Year Board Terms to Boost Governance Agility
Mar 13, 2026
Tri Chemical Laboratories Inc. plans to shorten directors’ terms from two years to one year by amending Article 22 of its Articles of Incorporation, subject to approval at the 48th Annual General Meeting of Shareholders on April 27, 2026. Th...
Tri Chemical Laboratories Sets Board and Auditor Slate Ahead of April Shareholders’ Meeting
Mar 13, 2026
Tri Chemical Laboratories Inc. has announced a slate of director candidates, primarily reappointments, including Chairman Jumpei Takenaka, CEO Kiyoshi Tazuke, and several executive and external directors, for approval at its 48th annual shareholde...
Tri Chemical Sets New Three-Year Plan on Strong Semiconductor Demand
Mar 13, 2026
Tri Chemical Laboratories has unveiled a new medium-term management plan covering the period from the fiscal year ending January 2027 through January 2029, targeting steady growth in sales and profits on the back of robust demand for advanced semi...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.